Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Nordic Nanovector ASA ( (DE:8NN) ) has provided an announcement.
Thor Medical ASA has announced the launch of a subsequent offering of up to 11,000,000 new shares at a subscription price of NOK 2.50 per share, aiming to raise up to NOK 27.5 million. The offering is available to shareholders registered by December 2024, excluding those in jurisdictions where such offerings would be unlawful, and is set to end on January 24, 2025. This initiative is anticipated to strengthen the company’s financial position, potentially impacting its operations and market standing in the radiopharmaceutical industry.
More about Nordic Nanovector ASA
Thor Medical ASA is an emerging supplier in the radiopharmaceutical industry, specializing in radionuclides, primarily alpha particle emitters, derived from naturally occurring thorium. The company operates with a proprietary production process that is environmentally friendly and cost-efficient, providing a reliable supply without the need for irradiation or nuclear reactors. Headquartered in Oslo, Norway, Thor Medical is listed on the Oslo Stock Exchange under the ticker symbol ‘TRMED’.
YTD Price Performance: -7.27%
Average Trading Volume: 5,299
Technical Sentiment Consensus Rating: Hold
Current Market Cap: €60.66M
See more insights into 8NN stock on TipRanks’ Stock Analysis page.
